P-gp protein expression was enhanced in TKI-naïve CML samples compared to healthy bone marrow samples, indicating a greater potential for efflux from leukemic cells before any exposure to TKIs [51]. The gene discussed is PGP; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.